scholarly article | Q13442814 |
P50 | author | Stefano Indraccolo | Q39186456 |
Elena Favaro | Q58314073 | ||
P2093 | author name string | Giorgia Nardo | |
Massimo Masiero | |||
P2860 | cites work | Mutations of the BRAF gene in human cancer | Q27860760 |
Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. | Q40435095 | ||
RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine | Q40609648 | ||
Telomere states and cell fates | Q46830116 | ||
P433 | issue | 1 | |
P921 | main subject | RNA interference | Q201993 |
P304 | page(s) | 143-166 | |
P577 | publication date | 2007-01-11 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Molecular Aspects of Medicine | Q6895933 |
P1476 | title | RNA interference: implications for cancer treatment | |
P478 | volume | 28 |
Q43846123 | Adenoviral delivered eGFP-intron splicing system for multiple gene RNAi |
Q37857396 | Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics? |
Q39018787 | Cancer-targeting siRNA delivery from porous silicon nanoparticles |
Q51001472 | Downregulation of ABCE1 via siRNA affects the sensitivity of A549 cells against chemotherapeutic agents |
Q39814192 | Downregulation of IGF-IR expression by RNAi inhibits proliferation and enhances chemosensitization of human colon cancer cells |
Q38204377 | Epigenetic biomarkers: potential applications in gastrointestinal cancers |
Q39989246 | Establishment of CXCR4-small interfering RNA retrovirus vector driven by human prostate-specific antigen promoter and its biological effects on prostate cancer in vitro and in vivo |
Q38396813 | Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma |
Q39632452 | In Vitro and In Vivo Inhibition of MRP Gene Expression and Reversal of Multidrug Resistance by siRNA |
Q27486413 | Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers |
Q34456173 | Inhibition of hepatitis B virus and induction of hepatoma cell apoptosis by ASGPR-directed delivery of shRNAs |
Q39643674 | Inhibitory Effect of Small Interfering RNA Targeting Insulin-Like Growth Factor-I Receptor in Ovarian Cancer OVCAR3 Cells |
Q42324117 | Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles |
Q33777055 | Is there a role for voltage-gated Na+ channels in the aggressiveness of breast cancer? |
Q37039021 | Liposomal nanomedicines |
Q46705002 | Liposomal nanomedicines: an emerging field |
Q38151549 | Nanooncology: the future of cancer diagnosis and therapy |
Q38037048 | Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy |
Q38743723 | RNAi Screening of the Glucose-Regulated Chaperones in Cancer with Self-Assembled siRNA Nanostructures |
Q35750000 | RNAi Targeting CXCR4 Inhibits Tumor Growth Through Inducing Cell Cycle Arrest and Apoptosis |
Q39735343 | Small interference RNA targeting Krüppel-like factor 8 inhibits the renal carcinoma 786-0 cells growth in vitro and in vivo |
Q58909203 | Superparamagnetic Nanoparticles and RNAi-Mediated Gene Silencing: Evolving Class of Cancer Diagnostics and Therapeutics |
Q33713264 | Targeting hypoxia-inducible factor-1alpha with Tf-PEI-shRNA complex via transferrin receptor-mediated endocytosis inhibits melanoma growth |
Search more.